Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Jun 2023
Historique:
received: 12 05 2023
revised: 29 05 2023
accepted: 31 05 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Psoriasis is a chronic inflammatory disease with an established genetic background. The HLA-Cw*06 allele and different polymorphisms in genes involved in inflammatory responses and keratinocyte proliferation have been associated with the development of the disease. Despite the effectiveness and safety of psoriasis treatment, a significant percentage of patients still do not achieve adequate disease control. Pharmacogenetic and pharmacogenomic studies on how genetic variations affect drug efficacy and toxicity could provide important clues in this respect. This comprehensive review assessed the available evidence for the role that those different genetic variations may play in the response to psoriasis treatment. One hundred fourteen articles were included in this qualitative synthesis.

Identifiants

pubmed: 37372997
pii: ijms24129850
doi: 10.3390/ijms24129850
pmc: PMC10298473
pii:
doi:

Substances chimiques

Tumor Necrosis Factor Inhibitors 0
Methotrexate YL5FZ2Y5U1
HLA-C Antigens 0
HLA Antigens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Eur Acad Dermatol Venereol. 2016 Mar;30 Suppl 2:1-18
pubmed: 26812550
Arch Dermatol Res. 2023 Jul;315(5):1241-1247
pubmed: 36513862
J Dermatol Sci. 2005 Mar;37(3):180-1
pubmed: 15734288
Pharmacogenomics J. 2018 Jan;18(1):70-75
pubmed: 27670765
J Invest Dermatol. 2008 Aug;128(8):1925-9
pubmed: 18256692
Int Immunopharmacol. 2015 Sep;28(1):146-53
pubmed: 26071216
Front Biosci (Landmark Ed). 2022 Sep 28;27(9):266
pubmed: 36224009
Pharmacogenomics J. 2018 May 22;18(3):494-500
pubmed: 28696418
Mol Diagn Ther. 2017 Jun;21(3):295-301
pubmed: 28130758
Br J Dermatol. 2018 Jan;178(1):86-94
pubmed: 28646581
J Am Acad Dermatol. 2015 Jul;73(1):37-49
pubmed: 26089047
J Clin Med. 2020 Jan 09;9(1):
pubmed: 31936662
Pharmaceutics. 2022 Nov 11;14(11):
pubmed: 36432633
Ann Dermatol. 2016 Feb;28(1):30-9
pubmed: 26848216
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e175-e177
pubmed: 30653751
Br J Dermatol. 2019 Oct;181(4):778-785
pubmed: 31020648
Vaccines (Basel). 2022 Nov 21;10(11):
pubmed: 36423071
Am J Hum Genet. 2006 May;78(5):827-851
pubmed: 16642438
J Dermatol. 2016 Nov;43(11):1273-1277
pubmed: 27129929
J Immunol Res. 2015;2015:101879
pubmed: 26613086
Pharmacogenomics. 2021 May;22(7):435-445
pubmed: 33887993
J Allergy Clin Immunol. 2019 Jun;143(6):2120-2130
pubmed: 30578879
J Autoimmun. 2015 Nov;64:66-73
pubmed: 26215033
J Invest Dermatol. 2016 Apr;136(4):779-787
pubmed: 26743604
JAMA Dermatol. 2013 Sep;149(9):1033-9
pubmed: 24048425
Br J Dermatol. 2016 Jul;175(1):134-41
pubmed: 26854129
Br J Dermatol. 2017 Aug;177(2):489-496
pubmed: 28207934
Pharmacogenomics J. 2018 Jan;18(1):76-80
pubmed: 27670766
J Pers Med. 2020 Dec 29;11(1):
pubmed: 33383665
Pharmacogenomics. 2015;16(12):1427-37
pubmed: 26244882
J Invest Dermatol. 2016 Dec;136(12):2364-2371
pubmed: 27476722
Medicina (Kaunas). 2020 Dec 20;56(12):
pubmed: 33419370
Ital J Dermatol Venerol. 2022 Apr;157(2):146-153
pubmed: 33982552
Dermatology. 2021;237(4):579-587
pubmed: 33582672
J Am Acad Dermatol. 2017 Mar;76(3):377-390
pubmed: 28212759
J Am Acad Dermatol. 2008 Jan;58(1):106-15
pubmed: 17936411
Dermatology. 2016;232(2):230-6
pubmed: 26678060
J Invest Dermatol. 2007 Aug;127(8):1860-7
pubmed: 17410198
J Am Acad Dermatol. 2020 Jan;82(1):256-257
pubmed: 31837740
Br J Dermatol. 2005 Jun;152(6):1304-12
pubmed: 15948997
Pharmacogenet Genomics. 2015 Jun;25(6):313-6
pubmed: 25794162
Genes (Basel). 2023 Feb 09;14(2):
pubmed: 36833372
Autoimmune Dis. 2013;2013:613086
pubmed: 24069534
Pharmacogenomics J. 2017 Jun;17(3):237-241
pubmed: 27044681
Br J Dermatol. 2010 Nov;163(5):1056-63
pubmed: 20716226
Cochrane Database Syst Rev. 2017 Dec 22;12:CD011535
pubmed: 29271481
Eur J Clin Pharmacol. 2017 Aug;73(8):965-971
pubmed: 28444425
Pharmacogenomics J. 2023 Jan;23(1):8-13
pubmed: 36229649
Pharmacogenomics J. 2015 Aug;15(4):322-5
pubmed: 25403996
Lancet. 2015 Sep 5;386(9997):983-94
pubmed: 26025581
Br J Dermatol. 2017 Apr;176(4):1001-1009
pubmed: 27579864
Exp Dermatol. 2015 Feb;24(2):146-7
pubmed: 25357087
J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1786-90
pubmed: 25726968
J Invest Dermatol. 2013 Feb;133(2):377-85
pubmed: 23014338
JAMA Dermatol. 2019 Jun 1;155(6):708-715
pubmed: 30994858
Pharmacogenet Genomics. 2016 Sep;26(9):423-7
pubmed: 27348478
Br J Dermatol. 2019 Aug;181(2):413-414
pubmed: 31001812
Immunol Invest. 2013;42(8):726-36
pubmed: 23844553
Am J Clin Dermatol. 2016 Feb;17(1):79-86
pubmed: 26547918
Med Sci Monit. 2012 Nov;18(11):CR661-6
pubmed: 23111742
J Dermatol Sci. 2015 Sep;79(3):305-7
pubmed: 26169344
Indian J Dermatol. 2019 May-Jun;64(3):192-200
pubmed: 31148857
Lancet. 2008 May 17;371(9625):1675-84
pubmed: 18486740
Mol Diagn Ther. 2018 Aug;22(4):471-474
pubmed: 29943154
J Am Acad Dermatol. 2019 May;80(5):1332-1343
pubmed: 30590074
J Clin Med. 2020 Sep 28;9(10):
pubmed: 32998429
Br J Dermatol. 2018 Mar;178(3):798-800
pubmed: 28369750
Psoriasis (Auckl). 2018 Mar 23;8:7-11
pubmed: 29721444
Hum Immunol. 2018 Apr;79(4):213-217
pubmed: 29454820
Br J Dermatol. 2008 Mar;158(3):558-66
pubmed: 18047523
JAMA Dermatol. 2015 Dec 1;151(12):1376-1378
pubmed: 26398016
Br J Dermatol. 2013 Aug;169(2):458-63
pubmed: 23521149
Lancet. 2008 May 17;371(9625):1665-74
pubmed: 18486739
Front Med (Lausanne). 2021 Dec 16;8:743180
pubmed: 34977058
Exp Dermatol. 2020 Dec;29(12):1225-1232
pubmed: 33058233
Pharmacogenomics J. 2014 Dec;14(6):523-5
pubmed: 24889923
Br J Dermatol. 2017 May;176(5):1288-1296
pubmed: 27564082
Photodermatol Photoimmunol Photomed. 2018 Sep;34(5):347-349
pubmed: 29763989
Pharmacogenet Genomics. 2005 May;15(5):349-55
pubmed: 15864137
Br J Dermatol. 2006 Feb;154(2):345-52
pubmed: 16433808
Arch Dermatol Res. 2015 Jul;307(5):405-12
pubmed: 25537528
Clin Exp Dermatol. 2017 Aug;42(6):651-655
pubmed: 28512993
J Invest Dermatol. 2006 Feb;126(2):453-9
pubmed: 16385345
Pharmacogenomics J. 2018 Dec;18(6):689-703
pubmed: 30237581
Biomed Pharmacother. 2023 Jun;162:114643
pubmed: 37031496
Int Immunopharmacol. 2015 Dec;29(2):947-949
pubmed: 26563541
Br J Dermatol. 2012 Feb;166(2):288-97
pubmed: 21985130
Int J Mol Sci. 2020 Oct 23;21(21):
pubmed: 33114187
Am J Clin Dermatol. 2018 Apr;19(2):209-222
pubmed: 28921458
Acta Derm Venereol. 2021 May 4;101(5):adv00448
pubmed: 33846759
Int J Mol Sci. 2017 Jan 29;18(2):
pubmed: 28146080
Br J Dermatol. 2007 Dec;157(6):1230-4
pubmed: 17916200
Expert Opin Biol Ther. 2020 Feb;20(2):173-182
pubmed: 31880166
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e274-e276
pubmed: 29356172
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e898-e900
pubmed: 34310775
Br J Dermatol. 2010 Sep;163(3):586-92
pubmed: 20633008
Sci Rep. 2018 Sep 4;8(1):13182
pubmed: 30181619
Front Pharmacol. 2022 Aug 19;13:968935
pubmed: 36059983
Per Med. 2018 May 1;15(3):181-188
pubmed: 29843550
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):112-118
pubmed: 31287604
Eur J Dermatol. 2017 Oct 1;27(5):528-530
pubmed: 29084639
Lancet. 2005 Oct 15-21;366(9494):1367-74
pubmed: 16226614
J Invest Dermatol. 2012 Mar;132(3 Pt 1):593-600
pubmed: 22113471
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e271-e275
pubmed: 32043647
Am J Clin Dermatol. 2018 Feb;19(1):1-13
pubmed: 29080066
Actas Dermosifiliogr. 2022 Mar;113(3):261-277
pubmed: 35526919
Front Immunol. 2022 Jan 27;12:815121
pubmed: 35154085
J Pers Med. 2021 Apr 12;11(4):
pubmed: 33921427
J Clin Med. 2022 Oct 22;11(21):
pubmed: 36362461
J Am Acad Dermatol. 2016 Feb;74(2):374-5
pubmed: 26775778
Pharmacogenet Genomics. 2012 Feb;22(2):134-42
pubmed: 22158445
Biomed Pharmacother. 2021 Jun;138:111456
pubmed: 33714108
J Dermatol. 2020 Apr;47(4):e110-e111
pubmed: 31872456
Front Pharmacol. 2022 Jun 24;13:937490
pubmed: 35814239
Life (Basel). 2021 Jun 16;11(6):
pubmed: 34208603
Genes (Basel). 2021 Sep 10;12(9):
pubmed: 34573380
J Eur Acad Dermatol Venereol. 2009 Jul;23(7):803-6
pubmed: 19309427
Dermatol Ther. 2014 Sep-Oct;27(5):284-9
pubmed: 24909182
J Dermatol Sci. 2019 Jan;93(1):8-13
pubmed: 30563733
Pharmacogenomics J. 2016 Aug;16(4):336-40
pubmed: 26194362
Pharmacogenomics. 2017 May;18(7):631-638
pubmed: 28470127
Br J Dermatol. 2013 Oct;169(4):819-29
pubmed: 23662788
Mol Diagn Ther. 2012 Feb 1;16(1):29-34
pubmed: 22111980
Trends Pharmacol Sci. 2014 Aug;35(8):384-96
pubmed: 24993164
PLoS One. 2019 Aug 14;14(8):e0220868
pubmed: 31412060
J Invest Dermatol. 1998 Mar;110(3):301-2
pubmed: 9506454
Clin Exp Dermatol. 2014 Jun;39(4):519-24
pubmed: 24758522
Biomed Res Int. 2018 Sep 23;2018:3140682
pubmed: 30345297
N Engl J Med. 2010 Jan 14;362(2):118-28
pubmed: 20071701
Pharmacogenomics J. 2017 Oct;17(5):395-402
pubmed: 28607506
Mol Diagn Ther. 2016 Jun;20(3):221-5
pubmed: 27043841
Pharmacogenomics. 2018 Jan;19(1):7-16
pubmed: 29192552
Mol Diagn Ther. 2019 Oct;23(5):627-633
pubmed: 31267486
J Am Acad Dermatol. 2020 Jun;82(6):1445-1486
pubmed: 32119894
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):2059-2065
pubmed: 32271961
Arch Dermatol Res. 2007 Dec;299(10):487-91
pubmed: 17763859
Pharmacogenomics. 2015;16(15):1723-31
pubmed: 26415694
J Immunol Res. 2019 Sep 10;2019:2546161
pubmed: 31583255
J Am Acad Dermatol. 2019 Sep;81(3):775-804
pubmed: 31351884
Exp Dermatol. 2018 Dec;27(12):1361-1371
pubmed: 30260532
Br J Dermatol. 2018 Nov;179(5):1072-1080
pubmed: 29704432
Pharmacogenomics. 2017 Jan;18(2):157-164
pubmed: 27977334
J Dermatol Sci. 2002 Nov;30(2):167-71
pubmed: 12413773
Dermatology. 2016;232(5):592-596
pubmed: 27591988
Expert Opin Biol Ther. 2021 Feb;21(2):259-270
pubmed: 33297781
Int J Mol Sci. 2019 Mar 23;20(6):
pubmed: 30909615
Front Cell Dev Biol. 2020 May 26;8:401
pubmed: 32528961
Br J Dermatol. 2014 Nov;171(5):1181-8
pubmed: 24734995
Am J Clin Dermatol. 2015 Aug;16(4):285-294
pubmed: 25963062
J Cell Mol Med. 2020 Dec;24(23):13554-13563
pubmed: 33128843
Eur J Dermatol. 2018 Apr 1;28(2):217-224
pubmed: 29619998

Auteurs

Emilio Berna-Rico (E)

Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.

Javier Perez-Bootello (J)

Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.

Carlota Abbad-Jaime de Aragon (C)

Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.

Alvaro Gonzalez-Cantero (A)

Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.
Faculty of Medicine, Universidad Francisco de Vitoria, 28223 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH